Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;50(4):1729-1742.
doi: 10.1007/s10508-020-01880-y. Epub 2021 May 5.

Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa

Affiliations

Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa

Richard Muhumuza et al. Arch Sex Behav. 2021 May.

Abstract

Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. Few studies have explored adolescents and young people's perspectives toward PrEP. We conducted 24 group discussions and 60 in-depth interviews with males and females aged 13-24 years in Uganda, Zimbabwe, and South Africa between September 2018 and February 2019. We used the framework approach to generate themes and key concepts for analysis following the social ecological model. Young people expressed a willingness to use PrEP and identified potential barriers and facilitators of PrEP uptake. Barriers included factors at individual (fear of HIV, fear of side effects, and PrEP characteristics), interpersonal (parental influence, absence of a sexual partner), community (peer influence, social stigma), institutional (long waiting times at clinics, attitudes of health workers), and structural (cost of PrEP and mode of administration, accessibility concerns) levels. Facilitators included factors at individual (high HIV risk perception and preventing HIV/desire to remain HIV negative), interpersonal (peer influence, social support and care for PrEP uptake), community (adequate PrEP information and sensitization, evidence of PrEP efficacy and safety), institutional (convenient and responsive services, provision of appropriate and sufficiently resourced services), and structural (access and availability of PrEP, cost of PrEP) levels. The findings indicated that PrEP is an acceptable HIV prevention method. PrEP uptake is linked to personal and environmental factors that need to be considered for successful PrEP roll-out. Multi-level interventions needed to promote PrEP uptake should consider the social and structural drivers and focus on ways that can inspire PrEP uptake and limit the barriers.

Keywords: Adolescents; Barriers; Facilitators; HIV prevention; PrEP.

PubMed Disclaimer

Conflict of interest statement

All authors declare they have no conflict of interest.

References

    1. Abraham BK, Gulick R. Next generation oral PrEP: Beyond tenofovir. Current Opinion in HIV and AIDS. 2012;7(6):600–606. doi: 10.1097/COH.0b013e328358b9ce. - DOI - PMC - PubMed
    1. Amico KR, Wallace M, Bekker L-G, Roux S, Atujuna M, Sebastian E, Grant RM. Experiences with HPTN 067/ADAPT study-provided open-label PrEP among women in Cape Town: Facilitators and barriers within a mutuality framework. AIDS and Behavior. 2017;21(5):1361–1375. doi: 10.1007/s10461-016-1458-y. - DOI - PMC - PubMed
    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Katabira E. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine. 2012;367(5):399–410. doi: 10.1056/NEJMoa1108524. - DOI - PMC - PubMed
    1. Barnett T, Seeley J, Levin J, Katongole J. Hope: A new approach to understanding structural factors in HIV acquisition. Global Public Health. 2015;10(4):417–437. doi: 10.1080/17441692.2015.1007154. - DOI - PubMed
    1. Bärnighausen K, Matse S, Hughey AB, Hettema A, Bärnighausen TW, McMahon SA. “We know this will be hard at the beginning, but better in the long term”: Understanding PrEP uptake in the general population in Eswatini. AIDS Care. 2019;32(2):267–273. doi: 10.1080/09540121.2019.1653437. - DOI - PubMed

Publication types

Substances